WHO ICTRP trial
Clinical trial for angelic enrich blood soup on secondary prevention of…
ChiCTR1900022996 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900022996 |
|---|---|
| Public title | Clinical trial for angelic enrich blood soup on secondary prevention of chemotherapy-related thrombocytopenia in malignant solid tumor |
| Scientific title | An open, randomized, single-center phase II trial for angelic enrich blood soup on secondary prevention of chemotherapy-related thrombocytopenia in malignant solid tumors |
| Primary sponsor | Daping Hospital, Army Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Malignant Solid Tumors |
| Interventions | Experimental group:chemotherapy plus ABES;Control group:chemotherapy |
| Registration date | May 6, 2019 |
| Target size | Experimental group:50;Control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: